TapewireFind a company

person · Reporting owner

Dittrich Thomas J.W.

Disclosed activity across 1 company

Tapewire entity
10286
SEC CIK
0001491654

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
AMGEN INCAMGN · Entity 2832EVP & CFOSeptember 01, 2026September 04, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

AMGEN INC

Report date September 01, 2026 · Filed September 04, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect16,860 Reported balance Holding disclosure · report date 2026-09-01 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 16,860

F1: These Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 8/7/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $410.95 · Expires 2036-08-07DirectNot disclosed Reported balance Holding disclosure · report date 2026-09-01 · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · Balance Not disclosed

F2: These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 8/7/2027.

Filing footnotes · ownership attribution and instrument terms

F1: These Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 8/7/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F2: These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 8/7/2027.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 21, 2014 Filed May 22, 2014 21:15 UTC AMGEN INC AMGN · Entity 2832 Exercise / conversionNqso (Right to Buy) · Derivative 2,150 $0.00 Strike: $58.43 $0.00
Disclosure

SEC source: 0001127602-14-018510 · form4.xml · derivative · entry 5

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,150 shares

Expires 2020-04-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 21, 2014 Filed May 22, 2014 21:15 UTC AMGEN INC AMGN · Entity 2832 Exercise / conversionNqso (Right to Buy) · Derivative 1,980 $0.00 Strike: $54.69 $0.00
Disclosure

SEC source: 0001127602-14-018510 · form4.xml · derivative · entry 4

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,040

Underlying: Common Stock · 1,980 shares

Expires 2021-04-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 21, 2014 Filed May 22, 2014 21:15 UTC AMGEN INC AMGN · Entity 2832 SaleCommon Stock 4,130 $112.83 $465,983.77
Disclosure

SEC source: 0001127602-14-018510 · form4.xml · nonDerivative · entry 3

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,589

F1 · price: The price reported is an average price. The prices ranged from $112.82 to $112.86 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer.

F2 · balance_after: The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 583 RSUs which vest in one installment of 583 on 4/25/2015; 938 RSUs which vest in two installments of 462 on 4/27/2015 and 476 on 4/27/2016; 942 RSUs which vest in annual installments of 310, 311 and 321 on 4/26/2015, 4/26/2016 and 4/26/2017, respectively; and 681 RSUs which vest in annual installments of 224, 225 and 232 on 4/25/2015, 4/25/2017 and 4/25/2018, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F3 · balance_after: These shares include 40 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Read SEC document
May 21, 2014 Filed May 22, 2014 21:15 UTC AMGEN INC AMGN · Entity 2832 Exercise / conversionCommon Stock 2,150 $58.43 $125,624.50
Disclosure

SEC source: 0001127602-14-018510 · form4.xml · nonDerivative · entry 2

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,719

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 21, 2014 Filed May 22, 2014 21:15 UTC AMGEN INC AMGN · Entity 2832 Exercise / conversionCommon Stock 1,980 $54.69 $108,286.20
Disclosure

SEC source: 0001127602-14-018510 · form4.xml · nonDerivative · entry 1

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,569

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 27, 2014 Filed Apr 29, 2014 21:38 UTC AMGEN INC AMGN · Entity 2832 Tax withholdingCommon Stock 10 $111.41 $1,114.10
Disclosure

SEC source: 0001127602-14-015506 · form4.xml · nonDerivative · entry 5

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,589

F2 · balance_after: The shares include the following RSUs granted under the Company's equity plans: 583 RSUs which vest in one installment of 583 on 4/25/2015; 938 RSUs which vest in two installments of 462 on 4/27/2015 and 476 on 4/27/2016; 942 RSUs which vest in annual installments of 310, 311 and 321 on 4/26/2015, 4/26/2016 and 4/26/2017, respectively; and 681 RSUs which vest in annual installments of 224, 225 and 232 on 4/25/2015, 4/25/2017 and 4/25/2018, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F3 · balance_after: These shares include 40 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Read SEC document
April 27, 2014 Filed Apr 29, 2014 21:38 UTC AMGEN INC AMGN · Entity 2832 Tax withholdingCommon Stock 255 $111.41 $28,409.55
Disclosure

SEC source: 0001127602-14-015506 · form4.xml · nonDerivative · entry 4

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,599

Read SEC document
April 26, 2014 Filed Apr 29, 2014 21:38 UTC AMGEN INC AMGN · Entity 2832 Tax withholdingCommon Stock 170 $111.41 $18,939.70
Disclosure

SEC source: 0001127602-14-015506 · form4.xml · nonDerivative · entry 3

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,854

Read SEC document
April 25, 2014 Filed Apr 29, 2014 21:38 UTC AMGEN INC AMGN · Entity 2832 GrantCommon Stock 681 $0.00 $0.00
Disclosure

SEC source: 0001127602-14-015506 · form4.xml · nonDerivative · entry 2

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,024

F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/25/2016, 4/25/2017 and 4/25/2018, respectively.

Read SEC document
April 25, 2014 Filed Apr 29, 2014 21:38 UTC AMGEN INC AMGN · Entity 2832 Tax withholdingCommon Stock 312 $113.72 $35,480.64
Disclosure

SEC source: 0001127602-14-015506 · form4.xml · nonDerivative · entry 1

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,343

Read SEC document
March 14, 2014 Filed Mar 18, 2014 20:24 UTC AMGEN INC AMGN · Entity 2832 Tax withholdingCommon Stock 2,316 $123.96 $287,091.36
Disclosure

SEC source: 0001127602-14-012013 · form4.xml · nonDerivative · entry 1

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,655

F1 · balance_after: The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 308 RSUs which fully vest on 4/26/2014; 1,149 RSUs which vest in annual installments of 566 and 583 on 4/25/2014 and 4/25/2015, respectively; 1,400 RSUs which vest in two equal installments of 462 each on 4/27/2014 and 4/27/2015 and one installment of 476 on 4/27/2016; and 942 RSUs which vest in annual installments of 310, 311 and 321 on 4/26/2015, 4/26/2016 and 4/26/2017, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F2 · balance_after: These shares include 57 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan, as amended and restated, and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Read SEC document
March 05, 2014 Filed Mar 7, 2014 22:33 UTC AMGEN INC AMGN · Entity 2832 GrantCommon Stock 4,207 $0.00 $0.00
Disclosure

SEC source: 0001127602-14-010754 · form4.xml · nonDerivative · entry 1

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,971

F1 · balance_after: The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 308 RSUs which fully vest on 4/26/2014; 1,149 RSUs which vest in annual installments of 566 and 583 on 4/25/2014 and 4/25/2015, respectively; 1,400 RSUs which vest in two equal installments of 462 each on 4/27/2014 and 4/27/2015 and one installment of 476 on 4/27/2016; and 942 RSUs which vest in annual installments of 310, 311 and 321 on 4/26/2015, 4/26/2016 and 4/26/2017, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F2 · balance_after: These shares include 26 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan, as amended and restated, and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Read SEC document
May 22, 2013 Filed May 24, 2013 21:18 UTC AMGEN INC AMGN · Entity 2832 Exercise / conversionNqso (Right to Buy) · Derivative 1,980 $0.00 Strike: $54.69 $0.00
Disclosure

SEC source: 0001127602-13-018291 · form4.xml · derivative · entry 7

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,020

Underlying: Common Stock · 1,980 shares

Expires 2021-04-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 22, 2013 Filed May 24, 2013 21:18 UTC AMGEN INC AMGN · Entity 2832 Exercise / conversionNqso (Right to Buy) · Derivative 2,150 $0.00 Strike: $58.43 $0.00
Disclosure

SEC source: 0001127602-13-018291 · form4.xml · derivative · entry 6

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,150

Underlying: Common Stock · 2,150 shares

Expires 2020-04-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 22, 2013 Filed May 24, 2013 21:18 UTC AMGEN INC AMGN · Entity 2832 Exercise / conversionNqso (Right to Buy) · Derivative 2,000 $0.00 Strike: $50.44 $0.00
Disclosure

SEC source: 0001127602-13-018291 · form4.xml · derivative · entry 5

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,000 shares

Expires 2016-04-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 22, 2013 Filed May 24, 2013 21:18 UTC AMGEN INC AMGN · Entity 2832 SaleCommon Stock 6,130 $104.78 $642,296.50
Disclosure

SEC source: 0001127602-13-018291 · form4.xml · nonDerivative · entry 4

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,733

F1 · price: The price reported is an average price. The prices ranged from $104.7601 to $104.83 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer.

F2 · balance_after: The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 308 RSUs which fully vest on 4/26/2014; 1,149 RSUs which vest in annual installments of 566 and 583 on 4/25/2014 and 4/25/2015, respectively; 1,400 RSUs which vest in two equal installments of 462 each on 4/27/2014 and 4/27/2015 and one installment of 476 on 4/27/2016; and 942 RSUs which vest in annual installments of 310, 311 and 321 on 4/26/2015, 4/26/2016 and 4/26/2017, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F3 · balance_after: These shares include 26 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan, as amended and restated, and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Read SEC document
May 22, 2013 Filed May 24, 2013 21:18 UTC AMGEN INC AMGN · Entity 2832 Exercise / conversionCommon Stock 1,980 $54.69 $108,286.20
Disclosure

SEC source: 0001127602-13-018291 · form4.xml · nonDerivative · entry 3

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,863

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 22, 2013 Filed May 24, 2013 21:18 UTC AMGEN INC AMGN · Entity 2832 Exercise / conversionCommon Stock 2,150 $58.43 $125,624.50
Disclosure

SEC source: 0001127602-13-018291 · form4.xml · nonDerivative · entry 2

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,883

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 22, 2013 Filed May 24, 2013 21:18 UTC AMGEN INC AMGN · Entity 2832 Exercise / conversionCommon Stock 2,000 $50.44 $100,880.00
Disclosure

SEC source: 0001127602-13-018291 · form4.xml · nonDerivative · entry 1

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,733

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 28, 2013 Filed Apr 30, 2013 21:14 UTC AMGEN INC AMGN · Entity 2832 Tax withholdingCommon Stock 91 $108.38 $9,862.58
Disclosure

SEC source: 0001127602-13-014769 · form4.xml · nonDerivative · entry 3

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,733

F2 · balance_after: The shares include the following RSUs granted under the Company's equity plans: 308 RSUs which fully vest on 4/26/2014; 1,149 RSUs which vest in annual installments of 566 and 583 on 4/25/2014 and 4/25/2015, respectively; 1,400 RSUs which vest in two equal installments of 462 each on 4/27/2014 and 4/27/2015 and one installment of 476 on 4/27/2016; and 942 RSUs which vest in annual installments of 310, 311 and 321 on 4/26/2015, 4/26/2016 and 4/26/2017, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F3 · balance_after: These shares include 26 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Read SEC document
April 26, 2013 Filed Apr 30, 2013 21:14 UTC AMGEN INC AMGN · Entity 2832 Tax withholdingCommon Stock 98 $108.66 $10,648.68
Disclosure

SEC source: 0001127602-13-014769 · form4.xml · nonDerivative · entry 2

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,824

Read SEC document
April 26, 2013 Filed Apr 30, 2013 21:14 UTC AMGEN INC AMGN · Entity 2832 GrantCommon Stock 942 $0.00 $0.00
Disclosure

SEC source: 0001127602-13-014769 · form4.xml · nonDerivative · entry 1

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,922

F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/26/2015, 4/26/2016 and 4/26/2017, respectively.

Read SEC document
April 25, 2013 Filed Apr 29, 2013 22:00 UTC AMGEN INC AMGN · Entity 2832 Tax withholdingCommon Stock 179 $104.93 $18,782.47
Disclosure

SEC source: 0001127602-13-014705 · form4.xml · nonDerivative · entry 1

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,980

F1 · balance_after: The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 286 RSUs which fully vest on 4/28/2013; 615 RSUs which vest in annual installments of 307 on 4/26/2013 and 308 on 4/26/2014; 1,149 RSUs which vest in annual installments of 566 and 583 on 4/25/2014 and 4/25/2015, respectively; and 1,400 RSUs which vest in two equal installments of 462 each on 4/27/2014 and 4/27/2015 and one installment of 476 on 4/27/2016. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F2 · balance_after: These shares include 26 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Read SEC document
March 15, 2013 Filed Mar 19, 2013 23:41 UTC AMGEN INC AMGN · Entity 2832 Tax withholdingCommon Stock 1,121 $92.18 $103,333.78
Disclosure

SEC source: 0001127602-13-011472 · form4.xml · nonDerivative · entry 1

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,159

F1 · balance_after: The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 286 RSUs which fully vest on 4/28/2013; 615 RSUs which vest in annual installments of 307 on 4/26/2013 and 308 on 4/26/2014; 1,714 RSUs which vest in annual installments of 565, 566 and 583 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively; and 1,400 RSUs which vest in two equal installments of 462 each on 4/27/2014 and 4/27/2015 and one installment of 476 on 4/27/2016. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F2 · balance_after: These shares include 26 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Read SEC document
March 06, 2013 Filed Mar 8, 2013 23:15 UTC AMGEN INC AMGN · Entity 2832 GrantCommon Stock 3,540 $0.00 $0.00
Disclosure

SEC source: 0001127602-13-010156 · form4.xml · nonDerivative · entry 1

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,273

F1 · balance_after: The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 286 RSUs which fully vest on 4/28/2013; 615 RSUs which vest in annual installments of 307 on 4/26/2013 and 308 on 4/26/2014; 1,714 RSUs which vest in annual installments of 565, 566 and 583 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively; and 1,400 RSUs which vest in two equal installments of 462 each on 4/27/2014 and 4/27/2015 and one installment of 476 on 4/27/2016. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F2 · balance_after: These shares include 19 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Read SEC document
July 31, 2012 Filed Aug 1, 2012 23:39 UTC AMGEN INC AMGN · Entity 2832 Exercise / conversionNqso (Right to Buy) · Derivative 2,150 $0.00 Strike: $58.43 $0.00
Disclosure

SEC source: 0001127602-12-023455 · form4.xml · derivative · entry 9

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,300

Underlying: Common Stock · 2,150 shares

Expires 2020-04-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 31, 2012 Filed Aug 1, 2012 23:39 UTC AMGEN INC AMGN · Entity 2832 Exercise / conversionNqso (Right to Buy) · Derivative 2,000 $0.00 Strike: $50.44 $0.00
Disclosure

SEC source: 0001127602-12-023455 · form4.xml · derivative · entry 8

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

Underlying: Common Stock · 2,000 shares

Expires 2016-04-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 31, 2012 Filed Aug 1, 2012 23:39 UTC AMGEN INC AMGN · Entity 2832 Exercise / conversionNqso (Right to Buy) · Derivative 3,000 $0.00 Strike: $42.13 $0.00
Disclosure

SEC source: 0001127602-12-023455 · form4.xml · derivative · entry 7

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,000 shares

Expires 2015-04-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 31, 2012 Filed Aug 1, 2012 23:39 UTC AMGEN INC AMGN · Entity 2832 Exercise / conversionNqso (Right to Buy) · Derivative 25,000 $0.00 Strike: $69.83 $0.00
Disclosure

SEC source: 0001127602-12-023455 · form4.xml · derivative · entry 6

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2013-05-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 31, 2012 Filed Aug 1, 2012 23:39 UTC AMGEN INC AMGN · Entity 2832 SaleCommon Stock 32,150 $82.69 $2,658,387.05
Disclosure

SEC source: 0001127602-12-023455 · form4.xml · nonDerivative · entry 5

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,721

F1 · price: The price reported is an average price. The prices ranged from $82.67 to $82.75 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer.

F2 · balance_after: The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 286 RSUs which fully vest on 4/28/2013; 615 RSUs which vest in annual installments of 307 on 4/26/2013 and 308 on 4/26/2014; 1,714 RSUs which vest in annual installments of 565, 566 and 583 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively; and 1,400 RSUs which vest in two equal installments of 462 each on 4/27/2014 and 4/27/2015 and one installment of 476 on 4/27/2016. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F3 · balance_after: These shares include 7 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Read SEC document
July 31, 2012 Filed Aug 1, 2012 23:39 UTC AMGEN INC AMGN · Entity 2832 Exercise / conversionCommon Stock 2,150 $58.43 $125,624.50
Disclosure

SEC source: 0001127602-12-023455 · form4.xml · nonDerivative · entry 4

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,871

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 31, 2012 Filed Aug 1, 2012 23:39 UTC AMGEN INC AMGN · Entity 2832 Exercise / conversionCommon Stock 2,000 $50.44 $100,880.00
Disclosure

SEC source: 0001127602-12-023455 · form4.xml · nonDerivative · entry 3

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,721

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 31, 2012 Filed Aug 1, 2012 23:39 UTC AMGEN INC AMGN · Entity 2832 Exercise / conversionCommon Stock 3,000 $42.13 $126,390.00
Disclosure

SEC source: 0001127602-12-023455 · form4.xml · nonDerivative · entry 2

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,721

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 31, 2012 Filed Aug 1, 2012 23:39 UTC AMGEN INC AMGN · Entity 2832 Exercise / conversionCommon Stock 25,000 $69.83 $1,745,750.00
Disclosure

SEC source: 0001127602-12-023455 · form4.xml · nonDerivative · entry 1

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,721

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 29, 2012 Filed May 2, 2012 00:45 UTC AMGEN INC AMGN · Entity 2832 Tax withholdingCommon Stock 233 $71.64 $16,692.12
Disclosure

SEC source: 0001127602-12-015249 · form4.xml · nonDerivative · entry 3

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,714

F2 · balance_after: The shares include the following RSUs granted under the Company's equity plans: 286 RSUs which fully vest on 4/28/2013; 615 RSUs which vest in annual installments of 307 on 4/26/2013 and 308 on 4/26/2014; 1,714 RSUs which vest in annual installments of 565, 566 and 583 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively; and 1,400 RSUs which vest in two equal installments of 462 each on 4/27/2014 and 4/27/2015 and one installment of 476 on 4/27/2016. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

Read SEC document
April 28, 2012 Filed May 2, 2012 00:45 UTC AMGEN INC AMGN · Entity 2832 Tax withholdingCommon Stock 78 $71.64 $5,587.92
Disclosure

SEC source: 0001127602-12-015249 · form4.xml · nonDerivative · entry 2

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,947

Read SEC document
April 27, 2012 Filed May 2, 2012 00:45 UTC AMGEN INC AMGN · Entity 2832 GrantCommon Stock 1,400 $0.00 $0.00
Disclosure

SEC source: 0001127602-12-015249 · form4.xml · nonDerivative · entry 1

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,025

F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/27/2014, 4/27/2015 and 4/27/2016, respectively.

Read SEC document
April 26, 2012 Filed Apr 30, 2012 22:03 UTC AMGEN INC AMGN · Entity 2832 Tax withholdingCommon Stock 84 $70.19 $5,895.96
Disclosure

SEC source: 0001127602-12-014979 · form4.xml · nonDerivative · entry 1

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,625

F1 · balance_after: The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 857 RSUs which fully vest on 4/29/2012; 572 RSUs which vest in two equal annual installments of 286 each commencing 4/28/2012; 615 RSUs which vest in annual installments of 307 on 4/26/2013 and 308 on 4/26/2014; and 1,714 RSUs which vest in annual installments of 565, 566 and 583 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

Read SEC document
March 16, 2012 Filed Mar 20, 2012 21:48 UTC AMGEN INC AMGN · Entity 2832 Tax withholdingCommon Stock 283 $68.26 $19,317.58
Disclosure

SEC source: 0001127602-12-011445 · form4.xml · nonDerivative · entry 1

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,709

F1 · balance_after: The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 857 RSUs which fully vest on 4/29/2012; 572 RSUs which vest in two equal annual installments of 286 each commencing 4/28/2012; 922 RSUs which vest in two equal installments of 307 each on 4/26/2012 and 4/26/2013 and one installment of 308 on 4/26/2014; and 1,714 RSUs which vest in annual installments of 565, 566 and 583 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

Read SEC document
March 14, 2012 Filed Mar 15, 2012 23:50 UTC AMGEN INC AMGN · Entity 2832 GrantCommon Stock 1,040 $0.00 $0.00
Disclosure

SEC source: 0001127602-12-010813 · form4.xml · nonDerivative · entry 1

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,992

F1 · balance_after: The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 857 RSUs which fully vest on 4/29/2012; 572 RSUs which vest in two equal annual installments of 286 each commencing 4/28/2012; 922 RSUs which vest in two equal installments of 307 each on 4/26/2012 and 4/26/2013 and one installment of 308 on 4/26/2014; and 1,714 RSUs which vest in annual installments of 565, 566 and 583 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

Read SEC document
January 30, 2012 Filed Feb 1, 2012 23:41 UTC AMGEN INC AMGN · Entity 2832 Exercise / conversionNqso (Right to Buy) · Derivative 2,150 $0.00 Strike: $58.43 $0.00
Disclosure

SEC source: 0001127602-12-003435 · form4.xml · derivative · entry 9

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,450

Underlying: Common Stock · 2,150 shares

Expires 2020-04-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 30, 2012 Filed Feb 1, 2012 23:41 UTC AMGEN INC AMGN · Entity 2832 Exercise / conversionNqso (Right to Buy) · Derivative 4,000 $0.00 Strike: $50.44 $0.00
Disclosure

SEC source: 0001127602-12-003435 · form4.xml · derivative · entry 8

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,000

Underlying: Common Stock · 4,000 shares

Expires 2016-04-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 30, 2012 Filed Feb 1, 2012 23:41 UTC AMGEN INC AMGN · Entity 2832 Exercise / conversionNqso (Right to Buy) · Derivative 9,000 $0.00 Strike: $42.13 $0.00
Disclosure

SEC source: 0001127602-12-003435 · form4.xml · derivative · entry 7

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000

Underlying: Common Stock · 9,000 shares

Expires 2015-04-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 30, 2012 Filed Feb 1, 2012 23:41 UTC AMGEN INC AMGN · Entity 2832 Exercise / conversionNqso (Right to Buy) · Derivative 11,000 $0.00 Strike: $62.55 $0.00
Disclosure

SEC source: 0001127602-12-003435 · form4.xml · derivative · entry 6

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,000 shares

Expires 2014-04-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 30, 2012 Filed Feb 1, 2012 23:41 UTC AMGEN INC AMGN · Entity 2832 SaleCommon Stock 26,150 $68.26 $1,784,931.01
Disclosure

SEC source: 0001127602-12-003435 · form4.xml · nonDerivative · entry 5

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,952

F1 · price: The price reported is an average price. The prices ranged from $68.21 to $68.29 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.

F2 · balance_after: The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 857 RSUs which fully vest on 4/29/2012; 572 RSUs which vest in two equal annual installments of 286 each commencing 4/28/2012; 922 RSUs which vest in two equal installments of 307 each on 4/26/2012 and 4/26/2013 and one installment of 308 on 4/26/2014; and 1,714 RSUs which vest in annual installments of 565, 566 and 583 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

Read SEC document
January 30, 2012 Filed Feb 1, 2012 23:41 UTC AMGEN INC AMGN · Entity 2832 Exercise / conversionCommon Stock 2,150 $58.43 $125,624.50
Disclosure

SEC source: 0001127602-12-003435 · form4.xml · nonDerivative · entry 4

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,102

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 30, 2012 Filed Feb 1, 2012 23:41 UTC AMGEN INC AMGN · Entity 2832 Exercise / conversionCommon Stock 4,000 $50.44 $201,760.00
Disclosure

SEC source: 0001127602-12-003435 · form4.xml · nonDerivative · entry 3

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,952

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 30, 2012 Filed Feb 1, 2012 23:41 UTC AMGEN INC AMGN · Entity 2832 Exercise / conversionCommon Stock 9,000 $42.13 $379,170.00
Disclosure

SEC source: 0001127602-12-003435 · form4.xml · nonDerivative · entry 2

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,952

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 30, 2012 Filed Feb 1, 2012 23:41 UTC AMGEN INC AMGN · Entity 2832 Exercise / conversionCommon Stock 11,000 $62.55 $688,050.00
Disclosure

SEC source: 0001127602-12-003435 · form4.xml · nonDerivative · entry 1

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,952

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 31, 2011 Filed Aug 3, 2011 00:59 UTC AMGEN INC AMGN · Entity 2832 Tax withholdingCommon Stock 679 $54.70 $37,141.30
Disclosure

SEC source: 0001127602-11-022646 · form4.xml · nonDerivative · entry 1

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,952

F1 · balance_after: These shares include the corrected beneficial ownership total, as amended by the Form 3/A filed on August 2, 2011. The shares also include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 857 RSUs which fully vest on 4/29/2012; 572 RSUs which vest in two equal annual installments of 286 each commencing 4/28/2012; 922 RSUs which vest in two equal installments of 307 each on 4/26/2012 and 4/26/2013 and one installment of 308 on 4/26/2014; and 1,714 RSUs which vest in annual installments of 565, 566 and 583 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.